National Healthcare Properties vs Chiron Real Estate
NHP and XRN side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How NHP and XRN compare
National Healthcare Properties is the larger company, worth 2.7 times as much as Chiron Real Estate ($1.1B against $402M).
Chiron Real Estate grew revenue faster over the last twelve months (8.0% versus −1.2% for National Healthcare Properties).
Both pay dividends: National Healthcare Properties yields 0.99% and Chiron Real Estate 7.0%.
Chiron Real Estate scores higher on the StockData Score (10 against 4 for National Healthcare Properties), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | NHP | XRN |
|---|---|---|
| Size and price | ||
| Market cap | $1.1B | $402M |
| Share price | $15.08 | $30.37 |
| Change, 1 year | – | −2.3% |
| Change, 5 years | – | −64.4% |
| Beta (5Y) | – | 0.87 |
| Employees | 31 | 30 |
| StockData Score | ||
| Total score | 4 | 10 (better) |
| Valuation score | 2 | 5 (better) |
| Growth score | 1 | 1 |
| Performance score | 0 | 0 |
| Health score | 0 | 0 |
| Dividend score | 1 | 4 (better) |
| Valuation | ||
| P/E | – | 8.2× |
| P/S | 3.2× | 2.6× (better) |
| P/B | 1.0× | 0.6× (better) |
| EV/EBITDA | 10.4× | – |
| Fair value | $15.73 | $103.94 |
| Margin of safety | 4.2% | 70.8% (better) |
| Growth | ||
| Revenue growth (TTM) | −1.2% | 8.0% (better) |
| Revenue growth, 5Y average | −2.2% | 9.6% (better) |
| EPS growth (TTM) | – | 994% |
| Profitability | ||
| Gross margin | 37.9% | – |
| Operating margin | 3.2% | – |
| Return on invested capital | 1.3% | – |
| Financial health | ||
| Interest coverage | 0.2× | – |
| Altman Z-score | 0.91 (better) | 0.15 |
| Dividends and buybacks | ||
| Dividend yield | 0.99% | 7.0% (better) |
| Shareholder yield | 0.99% | 7.0% (better) |
| Ownership | ||
| Held by institutions | 72.9% | 75.2% |
| Held by insiders | 0.35% | 2.3% |
| Insider net buying, 12 months | – | $4.0M |
| Short interest, % of float | 4.6% | 7.3% |
Go deeper
- NHP stock overview
- NHP income statement
- NHP valuation and score
- XRN stock overview
- XRN income statement
- XRN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.